GPX4 and hepatocellular carcinoma: The research found that the LINC01004/hsa-miR-125b-2-3p/HSPA4 axis inhibits ferroptosis in HCC cells by affecting GPX4 activity and iron metabolism, thereby influencing tumor progression.